Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...

PTC, Inc. is a global software company, which engages in the provision of a portfolio of innovative digital solutions that work together to transform how physical products are engineered ...

In a report released on November 8, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a ...

Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth quarter conference call. During this presen ...

the global leader in Configuration Lifecycle Management (CLM), today announced a strategic partnership and joint go-to-market strategy with PTC, a global software company that provides solutions ...

The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...

Engineering and design software provider PTC (NASDAQ:PTC ... 3D tours or interactive movies. Reviewing a company’s long-term performance can reveal insights into its business quality.

Analysts expect PTC to post earnings of $1.43 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. PTC (NASDAQ ...

Investors interested in PTC should track its annual recurring revenue (ARR) in addition to reported revenue. While reported revenue for a SaaS company can include low-margin items like ...